Steris (BSP:S1TE34) Net Income From Continuing Operations : R$1,861 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Steris Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Steris's net income from continuing operations for the three months ended in Mar. 2024 was R$-5 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was R$1,861 Mil.

Steris Net Income From Continuing Operations Historical Data

The historical data trend for Steris's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steris Net Income From Continuing Operations Chart

Steris Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Income From Continuing Operations

Get a 7-Day Free Trial

1,992.88

2,236.40

1,208.62

551.14

1,892.72

Steris Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															973.82	600.84	574.60	690.60	-4.99

Steris Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$1,861 Mil.

Steris (BSP:S1TE34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Steris PLC (BSP:S1TE34) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

STE:USA

Address

5960 Heisley Road, Mentor, OH, USA, 44060

Website

https://www.steris-ir.com

Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.

Steris (BSP:S1TE34) Headlines

No Headlines